FIB-4 as a Referral Index for Coronary Artery Calcification in MASLD

The Fibrosis-4 (FIB-4) index has emerged as a potentially valuable tool for assessing the risk of coronary artery calcification (CAC) in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). This study highlights the utility of FIB-4 as a noninvasive marker that can stratify cardiovascular risk and guide clinical decision-making in MASLD patients.

Key Findings:

1. Association Between MASLD and CAC:

• Individuals with MASLD were found to have a higher prevalence of coronary artery calcification compared to those without MASLD.
• This suggests that MASLD, which is characterized by steatotic liver disease and cardiometabolic risk factors, is closely linked to coronary atherosclerosis.

2. Role of FIB-4 Index:

• The FIB-4 index, a simple calculation based on age, platelet count, AST (aspartate aminotransferase), and ALT (alanine aminotransferase), was used to estimate liver fibrosis severity.
• Higher FIB-4 values were associated with more advanced coronary calcification, indicating a greater risk of coronary artery disease (CAD).
• Conversely, lower FIB-4 values were effective in identifying individuals at low risk of severe CAC.

3. Progressive Risk in MASLD:

• In MASLD patients, increasing liver fibrosis severity (reflected by higher FIB-4 values) corresponded with progressively higher coronary calcium levels.
• This relationship underscores the interconnectedness of liver fibrosis and cardiometabolic burden in driving coronary atherosclerosis.

Clinical Implications:

• Risk Stratification:

• FIB-4 can serve as a practical, noninvasive index to stratify cardiovascular risk in MASLD patients. Elevated FIB-4 values may identify individuals who require closer cardiovascular monitoring and intervention.

• Patients with low FIB-4 scores may be considered at lower risk for severe CAC, potentially reducing the need for more invasive diagnostic procedures.

• Early Preventive Care:

• Routine use of the FIB-4 index in MASLD patients can guide early preventive measures to mitigate cardiovascular risk, including lifestyle modifications, pharmacological interventions, and closer monitoring for coronary artery disease.

• Integration in Clinical Practice:

• The FIB-4 index is inexpensive, widely accessible, and easy to calculate, making it a feasible tool for routine use in primary care and specialized settings.

Conclusion:

The study underscores the clinical utility of the FIB-4 index as a referral index for coronary artery calcification in MASLD patients. By identifying individuals at increased risk of coronary atherosclerosis, FIB-4 can help optimize cardiovascular risk stratification and facilitate early preventive care. This approach may ultimately improve long-term outcomes for patients with MASLD and associated cardiometabolic conditions.